Literature DB >> 22588774

Measures of systemic sclerosis (scleroderma): Health Assessment Questionnaire (HAQ) and Scleroderma HAQ (SHAQ), physician- and patient-rated global assessments, Symptom Burden Index (SBI), University of California, Los Angeles, Scleroderma Clinical Trials Consortium Gastrointestinal Scale (UCLA SCTC GIT) 2.0, Baseline Dyspnea Index (BDI) and Transition Dyspnea Index (TDI) (Mahler's Index), Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR), and Raynaud's Condition Score (RCS).

Janet Pope1.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 22588774     DOI： 10.1002/acr.20598

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN： 2151-464X            Impact factor:   4.794


× No keyword cloud information.
  21 in total

1.  Assessment of nailfold capillaries with a handheld dermatoscope may discriminate the extent of organ involvement in patients with systemic sclerosis.

Authors:  Juan C Arana-Ruiz; Luis H Silveira; Diana Castillo-Martínez; Luis M Amezcua-Guerra
Journal:  Clin Rheumatol       Date:  2015-11-11       Impact factor: 2.980

2.  Cross-cultural adaptation and validation of the Brazilian version of the Scleroderma Health Assessment Questionnaire (SHAQ).

Authors:  Luiza F Rocha; Roberta G Marangoni; Percival D Sampaio-Barros; Mauricio Levy-Neto; Natalino H Yoshinari; Eloisa Bonfa; Virginia Steen; Sergio C Kowalski
Journal:  Clin Rheumatol       Date:  2013-08-22       Impact factor: 2.980

3.  Association between cortisol levels and pain threshold in systemic sclerosis and major depression.

Authors:  Gianluca Bagnato; Francesca Cordova; Davide Sciortino; Giovanni Miceli; Antonio Bruno; Antonino Ferrera; Donatella Sangari; Giovanni Coppolino; Maria R A Muscatello; Gianluca Pandolfo; Rocco A Zoccali; William N Roberts
Journal:  Rheumatol Int       Date:  2017-10-30       Impact factor: 2.631

Review 4.  [Systemic sclerosis : What is currently available for treatment?]

Authors:  M O Becker
Journal:  Internist (Berl)       Date:  2016-12       Impact factor: 0.743

Review 5.  Complementary therapies for patients with systemic sclerosis.

Authors:  Kimberly Showalter; Aileen Hoffmann; Nicole DeCredico; Anjali Thakrar; Esperanza Arroyo; Isaac Goldberg; Monique Hinchcliff
Journal:  J Scleroderma Relat Disord       Date:  2019-03-29

Review 6.  Patient-reported outcome instruments in clinical trials of systemic sclerosis.

Authors:  John D Pauling; Joana Caetano; Corrado Campochiaro; Giacomo De Luca; Ana Maria Gheorghiu; Maria Grazia Lazzaroni; Dinesh Khanna
Journal:  J Scleroderma Relat Disord       Date:  2019-11-25

Review 7.  Measuring response in the gastrointestinal tract in systemic sclerosis.

Authors:  Dinesh Khanna; Vivek Nagaraja; Heather Gladue; William Chey; Mark Pimentel; Tracy Frech
Journal:  Curr Opin Rheumatol       Date:  2013-11       Impact factor: 5.006

8.  High-intensity interval training can improve hand grip strength, inspiratory muscle, and quality of life in systemic sclerosis subjects.

Authors:  Irma Ruslina Defi; Chandrawati Gultom; Maria Jessica Chorman; Jennie Jennie
Journal:  Reumatologia       Date:  2021-04-27

Review 9.  The safety of biologic therapies in RA-associated interstitial lung disease.

Authors:  Meghna Jani; Nik Hirani; Eric L Matteson; William G Dixon
Journal:  Nat Rev Rheumatol       Date:  2013-12-24       Impact factor: 20.543

10.  Does hand involvement in systemic sclerosis limit completion of patient-reported outcome measures?

Authors:  Tracy M Frech; John M VanBuren; Emily Startup; Shervin Assassi; Elana J Bernstein; Flavia V Castelino; Lorinda Chung; Chase Correia; Jessica K Gordon; Faye N Hant; Laura Hummers; Dinesh Khanna; Nora Sandorfi; Ami A Shah; Victoria K Shanmugam; Virginia Steen; Luke Evnin
Journal:  Clin Rheumatol       Date:  2020-10-23       Impact factor: 2.980
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.